Stomach Cancer Treatment Market Size, Share & Trends Report

Stomach Cancer Treatment Market Size, Share & Trends Analysis Report By Treatment Type, By Disease Indication, By Route Of Administration, By Drug Class, By Distribution Channel, By Region, And Segment Forecasts, 2022 - 2030

Report ID: GVR-4-68039-973-9
Number of Pages: 140
Format: Electronic (PDF)

Historical Range: 2018 - 2020
Industry: Healthcare

Market Segmentation

Stomach Cancer Treatment Type Outlook (Patient Share, ;Revenue, USD Million, 2018 - 2030)
- Chemotherapy
- Immunotherapy
- Targeted therapy
- Radiation therapy and Surgery (Qualitative Analysis only)
Stomach Cancer Treatment Disease Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Gastric Cancer/Gastroesophageal Junction Cancer
- Gastrointestinal Stromal Tumors
Stomach Cancer Treatment Drug Class Outlook (Patient Share, Revenue, USD Million, 2018 - 2030)
- PD-1/PD-L1 inhibitors
- HER2 antagonists
- VEGFR2 antagonists
- Others
Stomach Cancer Treatment Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
- Oral
- Injectable
Stomach Cancer Treatment Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
- Hospital Pharmacies
- Specialty & Retail Pharmacies
- Others
Stomach Cancer Treatment Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Stomach Cancer Treatment Market, By Treatment Type
    - Chemotherapy
    - Immunotherapy
    - Targeted Therapy
  - North America Stomach Cancer Treatment Market, By Disease Indication
    - Gastric Cancer/Gastroesophageal Junction Cancer
    - Gastrointestinal Stromal Tumors
  - North America Stomach Cancer Treatment Market, By Route of Administration
    - Oral
    - Injectable
  - North America Stomach Cancer Treatment Market, By Drug Class
    - PD-1/PD-L1 inhibitors
    - HER2 antagonists
    - VEGFR2 antagonists
    - Others
  - North America Stomach Cancer Treatment Market, By Distribution Channel
    - Hospital Pharmacies
    - Specialty & Retail Pharmacies
    - Others
  - U.S.
    - U.S. Stomach Cancer Treatment Market, By Treatment Type
      - Chemotherapy
      - Immunotherapy
      - Targeted Therapy
    - U.S. Stomach Cancer Treatment Market, By Disease Indication
      - Gastric Cancer/Gastroesophageal Junction Cancer
      - Gastrointestinal Stromal Tumors
    - U.S. Stomach Cancer Treatment Market, By Route of Administration
      - Oral
      - Injectable
    - U.S. Stomach Cancer Treatment Market, By Drug Class
      - PD-1/PD-L1 inhibitors
      - HER2 antagonists
      - VEGFR2 antagonists
      - Others
    - U.S. Stomach Cancer Treatment Market, By Distribution Channel
      - Hospital Pharmacies
      - Specialty & Retail Pharmacies
      - Others
  - Canada
    - Canada Stomach Cancer Treatment Market, By Treatment Type
      - Chemotherapy
      - Immunotherapy
      - Targeted Therapy
    - Canada Stomach Cancer Treatment Market, By Disease Indication
      - Gastric Cancer/Gastroesophageal Junction Cancer
      - Gastrointestinal Stromal Tumors
    - Canada Stomach Cancer Treatment Market, By Route of Administration
      - Oral
      - Injectable
    - Canada Stomach Cancer Treatment Market, By Drug Class
      - PD-1/PD-L1 inhibitors
      - HER2 antagonists
      - VEGFR2 antagonists
      - Others
    - Canada Stomach Cancer Treatment Market, By Distribution Channel
      - Hospital Pharmacies
      - Specialty & Retail Pharmacies
      - Others
- Europe
  - Europe Stomach Cancer Treatment Market, By Treatment Type
    - Chemotherapy
    - Immunotherapy
    - Targeted Therapy
  - Europe Stomach Cancer Treatment Market, By Disease Indication
    - Gastric Cancer/Gastroesophageal Junction Cancer
    - Gastrointestinal Stromal Tumors
  - Europe Stomach Cancer Treatment Market, By Route of Administration
    - Oral
    - Injectable
  - Europe Stomach Cancer Treatment Market, By Drug Class
    - PD-1/PD-L1 inhibitors
    - HER2 antagonists
    - VEGFR2 antagonists
    - Others
  - Europe Stomach Cancer Treatment Market, By Distribution Channel
    - Hospital Pharmacies
    - Specialty & Retail Pharmacies
    - Others
  - U.K.
    - U.K. Stomach Cancer Treatment Market, By Treatment Type
      - Chemotherapy
      - Immunotherapy
      - Targeted Therapy
    - U.K. Stomach Cancer Treatment Market, By Disease Indication
      - Gastric Cancer/Gastroesophageal Junction Cancer
      - Gastrointestinal Stromal Tumors
    - U.K. Stomach Cancer Treatment Market, By Route of Administration
      - Oral
      - Injectable
    - U.K. Stomach Cancer Treatment Market, By Drug Class
      - PD-1/PD-L1 inhibitors
      - HER2 antagonists
      - VEGFR2 antagonists
      - Others
    - U.K. Stomach Cancer Treatment Market, By Distribution Channel
      - Hospital Pharmacies
      - Specialty & Retail Pharmacies
      - Others
  - Germany
    - Germany Stomach Cancer Treatment Market, By Treatment Type
      - Chemotherapy
      - Immunotherapy
      - Targeted Therapy
    - Germany Stomach Cancer Treatment Market, By Disease Indication
      - Gastric Cancer/Gastroesophageal Junction Cancer
      - Gastrointestinal Stromal Tumors
    - Germany Stomach Cancer Treatment Market, By Route of Administration
      - Oral
      - Injectable
    - Germany Stomach Cancer Treatment Market, By Drug Class
      - PD-1/PD-L1 inhibitors
      - HER2 antagonists
      - VEGFR2 antagonists
      - Others
    - Germany Stomach Cancer Treatment Market, By Distribution Channel
      - Hospital Pharmacies
      - Specialty & Retail Pharmacies
      - Others
  - France
    - France Stomach Cancer Treatment Market, By Treatment Type
      - Chemotherapy
      - Immunotherapy
      - Targeted Therapy
    - France Stomach Cancer Treatment Market, By Disease Indication
      - Gastric Cancer/Gastroesophageal Junction Cancer
      - Gastrointestinal Stromal Tumors
    - France Stomach Cancer Treatment Market, By Route of Administration
      - Oral
      - Injectable
    - France Stomach Cancer Treatment Market, By Drug Class
      - PD-1/PD-L1 inhibitors
      - HER2 antagonists
      - VEGFR2 antagonists
      - Others
    - France Stomach Cancer Treatment Market, By Distribution Channel
      - Hospital Pharmacies
      - Specialty & Retail Pharmacies
      - Others
  - Spain
    - Spain Stomach Cancer Treatment Market, By Treatment Type
      - Chemotherapy
      - Immunotherapy
      - Targeted Therapy
    - Spain Stomach Cancer Treatment Market, By Disease Indication
      - Gastric Cancer/Gastroesophageal Junction Cancer
      - Gastrointestinal Stromal Tumors
    - Spain Stomach Cancer Treatment Market, By Route of Administration
      - Oral
      - Injectable
    - Spain Stomach Cancer Treatment Market, By Drug Class
      - PD-1/PD-L1 inhibitors
      - HER2 antagonists
      - VEGFR2 antagonists
      - Others
    - Spain Stomach Cancer Treatment Market, By Distribution Channel
      - Hospital Pharmacies
      - Specialty & Retail Pharmacies
      - Others
  - Italy
    - Italy Stomach Cancer Treatment Market, By Treatment Type
      - Chemotherapy
      - Immunotherapy
      - Targeted Therapy
    - Italy Stomach Cancer Treatment Market, By Disease Indication
      - Gastric Cancer/Gastroesophageal Junction Cancer
      - Gastrointestinal Stromal Tumors
    - Italy Stomach Cancer Treatment Market, By Route of Administration
      - Oral
      - Injectable
    - Italy Stomach Cancer Treatment Market, By Drug Class
      - PD-1/PD-L1 inhibitors
      - HER2 antagonists
      - VEGFR2 antagonists
      - Others
    - Italy Stomach Cancer Treatment Market, By Distribution Channel
      - Hospital Pharmacies
      - Specialty & Retail Pharmacies
      - Others
- Asia Pacific
  - Asia Pacific Stomach Cancer Treatment Market, By Treatment Type
    - Chemotherapy
    - Immunotherapy
    - Targeted Therapy
  - Asia Pacific Stomach Cancer Treatment Market, By Disease Indication
    - Gastric Cancer/Gastroesophageal Junction Cancer
    - Gastrointestinal Stromal Tumors
  - Asia Pacific Stomach Cancer Treatment Market, By Route of Administration
    - Oral
    - Injectable
  - Asia Pacific Stomach Cancer Treatment Market, By Drug Class
    - PD-1/PD-L1 inhibitors
    - HER2 antagonists
    - VEGFR2 antagonists
    - Others
  - Asia Pacific Stomach Cancer Treatment Market, By Distribution Channel
    - Hospital Pharmacies
    - Specialty & Retail Pharmacies
    - Others
  - Japan
    - Japan Stomach Cancer Treatment Market, By Treatment Type
      - Chemotherapy
      - Immunotherapy
      - Targeted Therapy
    - Japan Stomach Cancer Treatment Market, By Disease Indication
      - Gastric Cancer/Gastroesophageal Junction Cancer
      - Gastrointestinal Stromal Tumors
    - Japan Stomach Cancer Treatment Market, By Route of Administration
      - Oral
      - Injectable
    - Japan Stomach Cancer Treatment Market, By Drug Class
      - PD-1/PD-L1 inhibitors
      - HER2 antagonists
      - VEGFR2 antagonists
      - Others
    - Japan Stomach Cancer Treatment Market, By Distribution Channel
      - Hospital Pharmacies
      - Specialty & Retail Pharmacies
      - Others
  - China
    - China Stomach Cancer Treatment Market, By Treatment Type
      - Chemotherapy
      - Immunotherapy
      - Targeted Therapy
    - China Stomach Cancer Treatment Market, By Disease Indication
      - Gastric Cancer/Gastroesophageal Junction Cancer
      - Gastrointestinal Stromal Tumors
    - China Stomach Cancer Treatment Market, By Route of Administration
      - Oral
      - Injectable
    - China Stomach Cancer Treatment Market, By Drug Class
      - PD-1/PD-L1 inhibitors
      - HER2 antagonists
      - VEGFR2 antagonists
      - Others
    - China Stomach Cancer Treatment Market, By Distribution Channel
      - Hospital Pharmacies
      - Specialty & Retail Pharmacies
      - Others
  - India
    - India Stomach Cancer Treatment Market, By Treatment Type
      - Chemotherapy
      - Immunotherapy
      - Targeted Therapy
    - India Stomach Cancer Treatment Market, By Disease Indication
      - Gastric Cancer/Gastroesophageal Junction Cancer
      - Gastrointestinal Stromal Tumors
    - India Stomach Cancer Treatment Market, By Route of Administration
      - Oral
      - Injectable
    - India Stomach Cancer Treatment Market, By Drug Class
      - PD-1/PD-L1 inhibitors
      - HER2 antagonists
      - VEGFR2 antagonists
      - Others
    - India Stomach Cancer Treatment Market, By Distribution Channel
      - Hospital Pharmacies
      - Specialty & Retail Pharmacies
      - Others
  - South Korea
    - South Korea Stomach Cancer Treatment Market, By Treatment Type
      - Chemotherapy
      - Immunotherapy
      - Targeted Therapy
    - South Korea Stomach Cancer Treatment Market, By Disease Indication
      - Gastric Cancer/Gastroesophageal Junction Cancer
      - Gastrointestinal Stromal Tumors
    - South Korea Stomach Cancer Treatment Market, By Route of Administration
      - Oral
      - Injectable
    - South Korea Stomach Cancer Treatment Market, By Drug Class
      - PD-1/PD-L1 inhibitors
      - HER2 antagonists
      - VEGFR2 antagonists
      - Others
    - South Korea Stomach Cancer Treatment Market, By Distribution Channel
      - Hospital Pharmacies
      - Specialty & Retail Pharmacies
      - Others
  - Australia
    - Australia Stomach Cancer Treatment Market, By Treatment Type
      - Chemotherapy
      - Immunotherapy
      - Targeted Therapy
    - Australia Stomach Cancer Treatment Market, By Disease Indication
      - Gastric Cancer/Gastroesophageal Junction Cancer
      - Gastrointestinal Stromal Tumors
    - Australia Stomach Cancer Treatment Market, By Route of Administration
      - Oral
      - Injectable
    - Australia Stomach Cancer Treatment Market, By Drug Class
      - PD-1/PD-L1 inhibitors
      - HER2 antagonists
      - VEGFR2 antagonists
      - Others
    - Australia Stomach Cancer Treatment Market, By Distribution Channel
      - Hospital Pharmacies
      - Specialty & Retail Pharmacies
      - Others
- Latin America
  - Latin America Stomach Cancer Treatment Market, By Treatment Type
    - Chemotherapy
    - Immunotherapy
    - Targeted Therapy
  - Latin America Stomach Cancer Treatment Market, By Disease Indication
    - Gastric Cancer/Gastroesophageal Junction Cancer
    - Gastrointestinal Stromal Tumors
  - Latin America Stomach Cancer Treatment Market, By Route of Administration
    - Oral
    - Injectable
  - Latin America Stomach Cancer Treatment Market, By Drug Class
    - PD-1/PD-L1 inhibitors
    - HER2 antagonists
    - VEGFR2 antagonists
    - Others
  - Latin America Stomach Cancer Treatment Market, By Distribution Channel
    - Hospital Pharmacies
    - Specialty & Retail Pharmacies
    - Others
  - Brazil
    - Brazil Stomach Cancer Treatment Market, By Treatment Type
      - Chemotherapy
      - Immunotherapy
      - Targeted Therapy
    - Brazil Stomach Cancer Treatment Market, By Disease Indication
      - Gastric Cancer/Gastroesophageal Junction Cancer
      - Gastrointestinal Stromal Tumors
    - Brazil Stomach Cancer Treatment Market, By Route of Administration
      - Oral
      - Injectable
    - Brazil Stomach Cancer Treatment Market, By Drug Class
      - PD-1/PD-L1 inhibitors
      - HER2 antagonists
      - VEGFR2 antagonists
      - Others
    - Brazil Stomach Cancer Treatment Market, By Distribution Channel
      - Hospital Pharmacies
      - Specialty & Retail Pharmacies
      - Others
  - Mexico
    - Mexico Stomach Cancer Treatment Market, By Treatment Type
      - Chemotherapy
      - Immunotherapy
      - Targeted Therapy
    - Mexico Stomach Cancer Treatment Market, By Disease Indication
      - Gastric Cancer/Gastroesophageal Junction Cancer
      - Gastrointestinal Stromal Tumors
    - Mexico Stomach Cancer Treatment Market, By Route of Administration
      - Oral
      - Injectable
    - Mexico Stomach Cancer Treatment Market, By Drug Class
      - PD-1/PD-L1 inhibitors
      - HER2 antagonists
      - VEGFR2 antagonists
      - Others
    - Mexico Stomach Cancer Treatment Market, By Distribution Channel
      - Hospital Pharmacies
      - Specialty & Retail Pharmacies
      - Others
  - Argentina
    - Argentina Stomach Cancer Treatment Market, By Treatment Type
      - Chemotherapy
      - Immunotherapy
      - Targeted Therapy
    - Argentina Stomach Cancer Treatment Market, By Disease Indication
      - Gastric Cancer/Gastroesophageal Junction Cancer
      - Gastrointestinal Stromal Tumors
    - Argentina Stomach Cancer Treatment Market, By Route of Administration
      - Oral
      - Injectable
    - Argentina Stomach Cancer Treatment Market, By Drug Class
      - PD-1/PD-L1 inhibitors
      - HER2 antagonists
      - VEGFR2 antagonists
      - Others
    - Argentina Stomach Cancer Treatment Market, By Distribution Channel
      - Hospital Pharmacies
      - Specialty & Retail Pharmacies
      - Others
- Middle East & Africa
  - Middle East & Africa Stomach Cancer Treatment Market, By Treatment Type
    - Chemotherapy
    - Immunotherapy
    - Targeted Therapy
  - Middle East & Africa Stomach Cancer Treatment Market, By Disease Indication
    - Gastric Cancer/Gastroesophageal Junction Cancer
    - Gastrointestinal Stromal Tumors
  - Middle East & Africa Stomach Cancer Treatment Market, By Route of Administration
    - Oral
    - Injectable
  - Middle East & Africa Stomach Cancer Treatment Market, By Drug Class
    - PD-1/PD-L1 inhibitors
    - HER2 antagonists
    - VEGFR2 antagonists
    - Others
  - Middle East & Africa Stomach Cancer Treatment Market, By Distribution Channel
    - Hospital Pharmacies
    - Specialty & Retail Pharmacies
    - Others
  - South Africa
    - South Africa Stomach Cancer Treatment Market, By Treatment Type
      - Chemotherapy
      - Immunotherapy
      - Targeted Therapy
    - South Africa Stomach Cancer Treatment Market, By Disease Indication
      - Gastric Cancer/Gastroesophageal Junction Cancer
      - Gastrointestinal Stromal Tumors
    - South Africa Stomach Cancer Treatment Market, By Route of Administration
      - Oral
      - Injectable
    - South Africa Stomach Cancer Treatment Market, By Drug Class
      - PD-1/PD-L1 inhibitors
      - HER2 antagonists
      - VEGFR2 antagonists
      - Others
    - South Africa Stomach Cancer Treatment Market, By Distribution Channel
      - Hospital Pharmacies
      - Specialty & Retail Pharmacies
      - Others
  - Saudi Arabia
    - Saudi Arabia Stomach Cancer Treatment Market, By Treatment Type
      - Chemotherapy
      - Immunotherapy
      - Targeted Therapy
    - Saudi Arabia Stomach Cancer Treatment Market, By Disease Indication
      - Gastric Cancer/Gastroesophageal Junction Cancer
      - Gastrointestinal Stromal Tumors
    - Saudi Arabia Stomach Cancer Treatment Market, By Route of Administration
      - Oral
      - Injectable
    - Saudi Arabia Stomach Cancer Treatment Market, By Drug Class
      - PD-1/PD-L1 inhibitors
      - HER2 antagonists
      - VEGFR2 antagonists
      - Others
    - Saudi Arabia Stomach Cancer Treatment Market, By Distribution Channel
      - Hospital Pharmacies
      - Specialty & Retail Pharmacies
      - Others
  - UAE
    - UAE Stomach Cancer Treatment Market, By Treatment Type
      - Chemotherapy
      - Immunotherapy
      - Targeted Therapy
    - UAE Stomach Cancer Treatment Market, By Disease Indication
      - Gastric Cancer/Gastroesophageal Junction Cancer
      - Gastrointestinal Stromal Tumors
    - UAE Stomach Cancer Treatment Market, By Route of Administration
      - Oral
      - Injectable
    - UAE Stomach Cancer Treatment Market, By Drug Class
      - PD-1/PD-L1 inhibitors
      - HER2 antagonists
      - VEGFR2 antagonists
      - Others
    - UAE Stomach Cancer Treatment Market, By Distribution Channel
      - Hospital Pharmacies
      - Specialty & Retail Pharmacies
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.